Dec
8
Wed
2021
Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting Abstract Deadline
Dec 8 all-day

SAGES 2022 ANNUAL MEETING THE NEXT BIG THING (FORMERLY EMERGING TECHNOLOGY) ABSTRACT SUBMISSION INFORMATION

SAGES 2022 Annual Meeting

March 16-19, 2022
Denver, CO

SAGES THE NEXT BIG THING (FORMERLY EMERGING TECHNOLOGY) SESSION SUBMISSION DEADLINE:
WEDNESDAY, DECEMBER 8, 2021 5:00 PM EST

Submit Your Abstract Now


You are invited to submit papers to The Next Big Thing (Formerly Emerging Technology) Session of the SAGES 2022 Annual Meeting. The meeting will be held March 16-19, 2022 in Denver, CO.

This session is open to submissions from physicians / industry engineers / scientists / researchers. It should be used for reporting on cutting edge or emerging technologies for which formal experimental data may not yet be available. Developers and inventors are encouraged to present their own work.

IF YOU ARE PLANNING TO SUBMIT OR DISCUSS ANY IDEAS OR INVENTIONS, before you submit or discuss them, please keep in mind that discussing or displaying them at this meeting may be considered a public disclosure of the idea or invention, which can negatively affect your right to protect that idea or invention. You may also have duties to your employer relating to that idea or invention, and should discuss the impact of a disclosure with the proper representatives of your employer before you submit or discuss it.

The Next Big Thing Abstracts will be accepted until December 8, 2021 and will undergo an expedited review process. This session is appropriate for technologies that may still be under development. Since The Next Big Thing session will not include CME credit, topics are not limited to formal studies or experiments but may include description based abstracts or very preliminary results. Presentations will be 5 to 10 minutes in length. Accepted abstracts will be published in the official SAGES Final Program.

Submissions should follow the following format:

  1. Objective of the technology or device
  2. Description of the technology and method of its use or application
  3. Preliminary results if available
  4. Conclusions / future directions
  5. 500-word limit

All abstracts for this session MUST BE SUBMITTED ONLINE


If you have any questions, please contact the SAGES office at 310-437-0544 (ext. 118) or email: abstracts@sages.org.

Submit Your Abstract Now

Feb
15
Tue
2022
American Society of Clinical Oncology Annual Meeting Abstract Deadline
Feb 15 all-day

June 3-7, 2022 • McCormick Place • Chicago, IL, Online

Abstract Submission

The 2022 Abstract Submitter will open on November 3rd. Browse our submission guidelines and prepare your research for submission.

For submission Guidelines & Requirements, see link: https://conferences.asco.org/am/abstract-submission

Feb
28
Mon
2022
Stanford Transplantation Surgical Fellowship Application Deadline
Feb 28 all-day
Mar
22
Tue
2022
Chandler Lecture
Mar 22 @ 7:00 am – 8:00 am
Sep
30
Fri
2022
24th Annual Fogarty Lecture
Sep 30 @ 4:00 pm – 5:00 pm

Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer.  The date of the event is Friday September 30, 2022 at 4pm.  It will be a hybrid event.

Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.

Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.

Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.

Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.

Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.

Oct
16
Sun
2022
American Society of Colon and Rectal Surgeons Meeting (ASCRS) Annual Meeting Abstract Deadline
Oct 16 all-day

The 2023 Abstract Submission Site is Now Open!

  SUBMIT AN ABSTRACT

Presentation Formats

  • Oral or ePoster: Abstracts submitted to this category will be competitively evaluated by the Program Committee for presentation in the oral, quick shot or ePoster format. Presentations selected will be eligible for annual awards including best overall, basic science or clinical paper presented from the podium or as an ePoster.
  • Oral Only: Abstracts submitted to this category will be competitively evaluated by the Program Committee for presentation in the oral format ONLY (Podium and Quick Shot). Abstracts will NOT be considered for ePoster presentation. Presentations selected will be eligible for annual awards including best overall, basic science or clinical paper presented from the podium.
  • ePoster Only: Abstracts submitted to this category will be evaluated for ePoster presentation only. Presentations selected will be eligible for best basic science or clinical e-poster.
  • Video: Abstracts submitted to this category will be competitively evaluated by the Video-Based Education Committee for presentation during the video abstract symposium and the Ongoing Video Room. Videos selected will be eligible for the best video award.
  • Case Study: Abstracts submitted to this category will be evaluated for ePoster presentation only.
  • Research Forum: Abstracts submitted to this category will be competitively evaluated by the Young Researchers Committee for oral presentation during the Research Forum. This session highlights developing areas of research that have clinical relevance for the care of patients with colorectal diseases. Presentations selected will be eligible for the Research in Progress award. If not accepted for Oral presentation the abstract will be considered for ePoster presentation.
  • New Technology: Abstracts submitted to this category will be competitively evaluated by the Program Committee in conjunction with the New Technologies Committee for oral presentation during the New Technology Symposium. This symposium highlights the development, integration, evaluation and dissemination of new technology in the practice of colon and rectal surgery. If not accepted for Oral presentation the abstract will be considered for e-poster presentation.

Dec
6
Tue
2022
Salvatierra Lecture: Velma Scantlebury
Dec 6 @ 7:00 am – 8:00 am